Tolmetin kinetics and synovial fluid prostaglandin E levels in rheumatoid arthritis.
Tolmetin kinetics were determined in the plasma and synovial fluid of five rheumatoid arthritis patients after they had ingested tolmetin (400 mg every 6 hr) for 7 days. Tolmetin was rapidly absorbed, with average peak levels in plasma and synovial fluid occurring at 45 min and 2 hr. The drug concentration in synovial fluid was higher than that in plasma for prolonged periods, while the rates of elimination from both plasma and synovial fluid were similar. The average half-lives of tolmetin in plasma and synovial fluid were 6.77 +/- 1.47 hr and 6.90 +/- 2.3 hr. Total prostaglandin E levels in synovial fluid of these patients were suppressed for at least 24 hr after the last dose of tolmetin, suggesting that PGE synthesis continues to be suppressed even by the very low concentrations of tolmetin remaining after 24 hr.
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D011458:Prostaglandins E / Q000032:analysis*; D011758:Pyrroles / Q000378:metabolism*; D013582:Synovial Fluid / Q000032:analysis* / Q000187:drug effects; D014046:Tolmetin / Q000032:analysis / Q000378:metabolism* / Q000627:therapeutic use
D011458:Prostaglandins E; D011758:Pyrroles; D014046:Tolmetin